Wuhan Jianmin Pharmaceutical Group Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Wuhan Jianmin Pharmaceutical Group Co., Ltd. with three other
companies in this sector in China:
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
sales of 2.45 billion Chinese Renmimbi [US$356.73 million]
of which 53%
was Medicine Manufacturing),
Jilin Aodong Medicine Industry (Group) Co., Ltd.
(2.33 billion Chinese Renmimbi [US$340.42 million]
of which 96%
was Pharmaceutical Manufacturing), and
Guangdong Taiantang Pharmaceutical Co Ltd
(2.37 billion Chinese Renmimbi [US$345.97 million]
of which 40%
was Medicine Wholesale & Retail).
Wuhan Jianmin Pharmaceutical Group Co., Ltd. reported sales of 2.28 billion Chinese Renmimbi (US$332.68 million)
December of 2015.
increase of 30.1%
versus 2014, when the company's sales were 1.75 billion Chinese Renmimbi.
Sales of Trade saw an increase
42.2% in 2015, from
1.13 billion Chinese Renmimbi to 1.61 billion Chinese Renmimbi.